Showing results (71-80 of 129) with videos related to
Sort By:
Pageof 13
Cancer|December 22, 2017
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phaseKoji Sasaki, Hagop Kantarjian, Susan O'Brien, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation FailureUri Rozovski, Ohad Benjamini, Preetesh Jain, et al.Cell Death & Disease|November 3, 2023
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteinsYijing Li, Heng-Huan Lee, Vivian Changying Jiang, et al.Blood Advances|July 11, 2019
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphomaMatthew S Ning, Chelsea C Pinnix, Bhavana V Chapman, et al.American Journal of Hematology|November 5, 2014
Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemiaTapan M Kadia, Hagop M Kantarjian, Deborah A Thomas, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2022
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia CellsUri Rozovski, Ivo Veletic, David M Harris, et al.Human Pathology|February 1, 2024
Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphomaAndres E Quesada, Shimin Hu, Shaoying Li, et al.Cancer|December 4, 2018
Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformationRashmi Kanagal-Shamanna, Preetesh Jain, Keyur P Patel, et al.Blood Advances|March 20, 2019
Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIsPreetesh Jain, Hagop Kantarjian, Prajwal C Boddu, et al.International Journal of Hematology|March 5, 2019
Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Susan O'Brien, et al.Pageof 13